Nutrition Supplementation in Hospitalized Patients (NutriSup Oral)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Malnutrition
- Sponsor
- Lawson Health Research Institute
- Enrollment
- 63
- Locations
- 1
- Primary Endpoint
- Hospital Readmission Rate
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this pilot study is to determine the effect of 3 months use of enhanced Oral Nutritional Supplement (ONS) on physical function and functional performance in malnourished elderly patients.
Detailed Description
The purpose of this pilot study is to determine the effect of 3 months use of enhanced Oral Nutritional Supplementation (ONS) on muscle accretion and functional performance in malnourished elderly patients. The objectives of this study are to determine feasibility of recruitment, adherence to intervention and retention of the sample, as well as the capacity of subjects to complete functional and muscle mass measures for a planned multi-centre Randomized Controlled Trial (RCT).
Investigators
Eligibility Criteria
Inclusion Criteria
- •admitted to a general medical ward and recruited within 48 hours
- •over the age of 65 years
- •malnourished (subjective global assessment categories B or C patients)
Exclusion Criteria
- •have an allergy or intolerance to any component of the oral supplement
- •are designated palliative care
- •are currently suffering from refeeding syndrome
- •have a pre-existing medical condition that prevents oral intake of full fluids,
- •have an expected length of stay of less than 48 hours from the time of assessment
- •have suspected ischemic stroke as cause for admission
- •reside in a residential care home
- •are unable to walk prior to current illness.
- •are pregnant/breastfeeding
- •have a current diagnosis of diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome
Outcomes
Primary Outcomes
Hospital Readmission Rate
Time Frame: 90 days
The number of participants who are re-admitted to hospital within 90 days of randomization. This healthcare utilization outcome will be used to determine the cost-benefit of enhanced Oral Nutritional Supplementation.
Secondary Outcomes
- Successful recruitment(1 year)
- Adherence to treatment(90 days)